PMID- 29848923 OWN - NLM STAT- MEDLINE DCOM- 20190523 LR - 20190523 IS - 2149-2271 (Electronic) IS - 2149-2263 (Print) IS - 2149-2263 (Linking) VI - 19 IP - 6 DP - 2018 Jun TI - Speckle-tracking strain assessment of left ventricular dysfunction in synthetic cannabinoid and heroin users. PG - 388-393 LID - 10.14744/AnatolJCardiol.2018.76429 [doi] AB - OBJECTIVE: There is growing evidence regarding the numerous adverse effects of synthetic cannabinoids (SCBs) on the cardiovascular system; however, no studies have shown the cardiovascular effects of opioids using strain echocardiography. This study examines the cardiac structure and function using echocardiographic strain imaging in heroin and synthetic cannabinoid users. METHODS: This double-blind study included patients who were admitted or referred to a rehabilitation center for heroin (n=31) and synthetic cannabinoid users (n=30). Heroin users and synthetic cannabinoid users were compared with healthy volunteers (n=32) using two-dimensional (2D) speckle-tracking (ST) echocardiography. RESULTS: No differences were found in the baseline characteristics and 2D echocardiography values. The mean global longitudinal strain value was -20.5%+/-2.4% for SCB users, -22.3%+/-2.4% for opioid users, and -22.5%+/-2.2% for healthy volunteers (p=0.024). The mean apical 2-chamber (AP2C) L-strain values were -20.1%+/-3.1%, -22.4%+/-3.0%, and -22.3%+/-2.8% for SCB users, opioid users, and healthy volunteers, respectively (p=0.032). The mean apical 4-chamber (AP4C) L-strain values were -20.7%+/-2.5% for SCB users, -23.2%+/-3.2% for opioid users, and -23.8%+/-3.1% for healthy volunteers (p<0.001). CONCLUSION: SCBs are potential causes of subclinical left ventricular dysfunction. FAU - Demirkiran, Aykut AU - Demirkiran A AD - Department of Cardiology, Tekirdag Corlu State Hospital; Tekirdag-Turkey. aykut_wax@hotmail.com. FAU - Albayrak, Neslihan AU - Albayrak N FAU - Albayrak, Yakup AU - Albayrak Y FAU - Zorkun, Cafer Sadik AU - Zorkun CS LA - eng PT - Journal Article PL - Turkey TA - Anatol J Cardiol JT - Anatolian journal of cardiology JID - 101652981 RN - 0 (Cannabinoids) RN - 70D95007SX (Heroin) SB - IM CIN - Anatol J Cardiol. 2018 Oct;20(4):252. PMID: 30297586 MH - Cannabinoids/*adverse effects/chemical synthesis MH - Case-Control Studies MH - Double-Blind Method MH - Echocardiography MH - Female MH - Heroin/*adverse effects MH - Humans MH - Male MH - Prospective Studies MH - Sensitivity and Specificity MH - Substance-Related Disorders/*diagnostic imaging MH - Ventricular Dysfunction, Left/*chemically induced/diagnostic imaging MH - Young Adult PMC - PMC5998859 COIS- Conflict of interest: None declared. EDAT- 2018/06/01 06:00 MHDA- 2019/05/24 06:00 PMCR- 2018/06/01 CRDT- 2018/06/01 06:00 PHST- 2018/06/01 06:00 [entrez] PHST- 2018/06/01 06:00 [pubmed] PHST- 2019/05/24 06:00 [medline] PHST- 2018/06/01 00:00 [pmc-release] AID - AJC-19-388 [pii] AID - 10.14744/AnatolJCardiol.2018.76429 [doi] PST - ppublish SO - Anatol J Cardiol. 2018 Jun;19(6):388-393. doi: 10.14744/AnatolJCardiol.2018.76429.